Can CDMOs keep up with the increasing demand for GLP-1 medications?
The wildly popular drugs, prescribed for weight loss and type 2 diabetes, are putting a strain on the capabilities of contract development and manufacturing organizations.
Can CDMOs keep up with the increasing demand for GLP-1 medications?
The wildly popular drugs, prescribed for weight loss and type 2 diabetes, are putting a strain on the capabilities of contract development and manufacturing organizations.